{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:39Z","timestamp":1792787979118,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health commission of shanxi province","award":["2023XG040"],"award-info":[{"award-number":["2023XG040"]}],"id":[{"id":"https:\/\/ror.org\/01nzpmv06","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-026-09623-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:05:11Z","timestamp":1784073911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of the short agonist stop protocol versus the long GnRH agonist protocol in poor ovarian responders undergoing IVF\/ICSI: a retrospective analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xue-Luo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"6","key":"9623_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","volume":"30","author":"P Patrizio","year":"2015","unstructured":"Patrizio P, Vaiarelli A, Levi Setti PE, et al. How to define, diagnose and treat poor responders? responses from a worldwide survey of IVF clinics. Reprod BioMed Online. 2015;30(6):581\u201392.","journal-title":"Reprod BioMed Online"},{"issue":"4","key":"9623_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/09513599409023632","volume":"8","author":"Z Ben-Rafael","year":"1994","unstructured":"Ben-Rafael Z, Orvieto R, Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol. 1994;8(4):277\u201386.","journal-title":"Gynecol Endocrinol"},{"key":"9623_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fendo.2020.00192","volume":"11","author":"Z Blumenfeld","year":"2020","unstructured":"Blumenfeld Z. What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART\/IVF? Front Endocrinol (Lausanne). 2020;11:192.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"9623_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gofs.2016.12.023","volume":"45","author":"M Duport Percier","year":"2017","unstructured":"Duport Percier M, Anahory T, Ranisavljevic N, et al. Mauvaises repondeuses: peut-on ameliorer nos resultats? Gynecologie Obstetrique Fertil Senologie. 2017;45(2):95\u2013103.","journal-title":"Gynecologie Obstetrique Fertil Senologie"},{"key":"9623_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/2311-8571.378173","volume":"9","author":"SA Pan","year":"2023","unstructured":"Pan SA, Murong ZM, Zhu YL, Song JW, Chang XR, Liu Y, et al. Discussion on relationship between meridians and viscera of decreased ovarian reserve from the perspective of preventive treatment of disease by acupuncture. World J Tradit Chin Med. 2023;9:111\u201322.","journal-title":"World J Tradit Chin Med"},{"key":"9623_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/2311-8571.393752","volume":"10","author":"E Najafi","year":"2024","unstructured":"Najafi E, Hoolari BB, Karimi A, Pilehvarian A. Examining the effect of hydroalcoholic extract of Dracaena cinnabari on sex hormones and ovarian and uterine tissues of rats. World J Tradit Chin Med. 2024;10:213\u20139.","journal-title":"World J Tradit Chin Med"},{"issue":"7","key":"9623_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, et al. ESHRE consensus on the definition of \u00ab poor response \u00bb to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"key":"9623_CR8","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","volume":"5","author":"P Humaidan","year":"2016","unstructured":"Humaidan P, Alviggi C, Fischer R, et al. The novel POSEIDON stratification of \u2018Low prognosis patients in assisted reproductive technology\u2019 and its proposed marker of successful outcome. F1000Research. 2016;5:2911.","journal-title":"F1000Research"},{"issue":"5","key":"9623_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0015-0282(98)00040-5","volume":"69","author":"BM Faber","year":"1998","unstructured":"Faber BM, Mayer J, Cox B, Oehninger S, Muasher SJ, et al. Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril. 1998;69(5):826\u201330.","journal-title":"Fertil Steril"},{"key":"9623_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fendo.2020.00182","volume":"11","author":"R Orvieto","year":"2020","unstructured":"Orvieto R, Kirshenbaum M, Galiano V, et al. Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With Genuine Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF. Front Endocrinol (Lausanne). 2020;11:182.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"9623_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1023\/A:1009476411762","volume":"18","author":"M Schachter","year":"2001","unstructured":"Schachter M, Friedler S, Raziel A, et al. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase\u2013a function of improved embryo quality. J Assist Reprod Genet. 2001;18(4):197\u2013204.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"9623_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0015-0282(16)55806-3","volume":"59","author":"A Hazout","year":"1993","unstructured":"Hazout A, de Ziegler D, Cornel C, et al. Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation. Fertil Steril. 1993;59(3):596\u2013600.","journal-title":"Fertil Steril"},{"issue":"1","key":"9623_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.fertnstert.2007.06.022","volume":"90","author":"R Orvieto","year":"2008","unstructured":"Orvieto R, Kruchkovich J, Rabinson J, et al. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization\/embryo transfer programs. Fertil Steril. 2008;90(1):228\u201330.","journal-title":"Fertil Steril"},{"key":"9623_CR14","doi-asserted-by":"publisher","unstructured":"Maheshwari A, Gibreel A, Siristatidis CS, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database Syst Rev. 2011;(8):CD006919. https:\/\/doi.org\/10.1002\/14651858.CD006919.","DOI":"10.1002\/14651858.CD006919"},{"key":"9623_CR15","doi-asserted-by":"crossref","unstructured":"Reproductive endocrinology guideline group ovarian. Stimulation for IVF\/ICSI. Available at: https:\/\/www.eshre.eu\/Guidelines-and-Legal\/Guidelines\/Ovarian-Stimulation-in-IVF-ICSI. Accessed 3 Apr 2020.","DOI":"10.1093\/hropen\/hoaa067"},{"key":"9623_CR16","doi-asserted-by":"publisher","first-page":"1056520","DOI":"10.3389\/fendo.2022.1056520","volume":"13","author":"C Mauries","year":"2022","unstructured":"Mauries C, Ranisavljevic N, Mollevi C, et al. Short agonist stop protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study. Front Endocrinol (Lausanne). 2022;13:1056520.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"9623_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"9623_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5935\/1518-0557.20210048","volume":"26","author":"R Nakano","year":"2022","unstructured":"Nakano R, Radaelli MRM, Fujihara LS, Yoshinaga F, Nakano E, Almodin CG. Efficacy of a modified transvaginal ultrasound-guided fresh embryo transfer procedure. JBRA Assist Reprod. 2022;26(1):78\u201383. https:\/\/doi.org\/10.5935\/1518-0557.20210048 . PMID: 34415124; PMCID: PMC8769173.","journal-title":"JBRA Assist Reprod"},{"key":"9623_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/humrep\/deq361","volume":"26","author":"VK Genro","year":"2011","unstructured":"Genro VK, Grynberg M, Scheffer JB, et al. Serum Anti-M\u00fcllerian Hormone Levels Are Negatively Related to Follicular Output RaTe (FORT) in Normo-Cycling Women Undergoing Controlled Ovarian Hyperstimulation. Hum Reprod. 2011;26:671\u20137.","journal-title":"Hum Reprod"},{"key":"9623_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","volume":"9","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, et al. Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker\u2014The Follicle-to-Oocyte (FOI) Index. Front Endocrinol (Lausanne). 2018;9:589.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"01","key":"9623_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3969\/j.issn.2095-5227.2021.01.011","volume":"42","author":"C Yanfei","year":"2021","unstructured":"Yanfei C, Jing W, Hui W, Jinning Z, Qi Z, Yuanqing Y Three ovarian stimulation protocols for infertile patients with poor ovarian response. Acad J Chin PLA Med Sch. 2021;42(01):48\u201352. https:\/\/doi.org\/10.3969\/j.issn.2095-5227.2021.01.011.","journal-title":"Acad J Chin PLA Med Sch"},{"issue":"7","key":"9623_CR22","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768\u201374.","journal-title":"Hum Reprod"},{"issue":"2","key":"9623_CR23","first-page":"370","volume":"31","author":"P Drakopoulos","year":"2016","unstructured":"Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP. Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31(2):370\u20136.","journal-title":"Hum Reprod"},{"issue":"11","key":"9623_CR24","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/humrep\/15.11.2292","volume":"15","author":"JA Garcia-Velasco","year":"2000","unstructured":"Garcia-Velasco JA, Isaza V, Requena A, Mart\u00ednez-Salazar FJ, Landaz\u00e1bal A, Remoh\u00ed J, Pellicer A, Sim\u00f3n C. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod. 2000;15(11):2292\u20136.","journal-title":"Hum Reprod"},{"issue":"2","key":"9623_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0015-0282(16)54114-4","volume":"55","author":"Z Ben-Rafael","year":"1991","unstructured":"Ben-Rafael Z, Lipitz S, Bider D, Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril. 1991;55(2):272\u20135.","journal-title":"Fertil Steril"},{"issue":"6","key":"9623_CR26","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.fertnstert.2014.02.036","volume":"101","author":"A Kedem","year":"2014","unstructured":"Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R. Is the modified natural in vitro fertilization cycle justified in patients with genuine poor response to controlled ovarian hyperstimulation? Fertil Steril. 2014;101(6):1624\u20138.","journal-title":"Fertil Steril"},{"issue":"2","key":"9623_CR27","first-page":"114","volume":"154","author":"J Haas","year":"2015","unstructured":"Haas J, Zilberberg E, Kedem A, Dar S, Orvieto R. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?]. Harefuah. 2015;154(2):114\u20137.","journal-title":"Harefuah"},{"issue":"4","key":"9623_CR28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0015-0282(99)00630-5","volume":"73","author":"ES Surrey","year":"2000","unstructured":"Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73(4):667\u201376.","journal-title":"Fertil Steril"},{"issue":"9","key":"9623_CR29","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/humrep\/17.9.2287","volume":"17","author":"EA Pritts","year":"2002","unstructured":"Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod. 2002;17(9):2287\u201399.","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"9623_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000513669","volume":"86","author":"R Orvieto","year":"2021","unstructured":"Orvieto R, Nahum R, Aizer A, Haas J, Kirshenbaum M. A Novel Stimulation Protocol for Poor-Responder Patients: Combining the Stop GnRH-ag Protocol with Letrozole Priming and Multiple-Dose GnRH-ant: A Proof of Concept. Gynecol Obstet Invest. 2021;86(1\u20132):149\u201354.","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"9623_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","volume":"35","author":"J Haas","year":"2019","unstructured":"Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, Orvieto R. Does double trigger (GnRH-agonist\u2009+\u2009hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecol Endocrinol. 2019;35(7):628\u201330.","journal-title":"Gynecol Endocrinol"},{"key":"9623_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","volume":"8","author":"R Orvieto","year":"2015","unstructured":"Orvieto R. Triggering final follicular maturation\u2013hCG, GnRH-agonist or both, when and to whom? J Ovarian Res. 2015;8:60.","journal-title":"J Ovarian Res"},{"issue":"5","key":"9623_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000517177","volume":"86","author":"R Orvieto","year":"2021","unstructured":"Orvieto R, Nahum R, Frei J, Zandman O, Frenkel Y, Haas J. GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol. Gynecol Obstet Invest. 2021;86(5):427\u201331.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"9623_CR34","doi-asserted-by":"publisher","first-page":"15793","DOI":"10.1038\/s41598-020-72597-0","volume":"10","author":"S Yildiz","year":"2020","unstructured":"Yildiz S, Yakin K, Ata B, Oktem O. There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles. Sci Rep. 2020;10(1):15793.","journal-title":"Sci Rep"},{"issue":"7","key":"9623_CR35","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/humrep\/deaa137","volume":"35","author":"PA Romanski","year":"2020","unstructured":"Romanski PA, Bortoletto P, Rosenwaks Z, Schattman GL. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod. 2020;35(7):1630\u20136.","journal-title":"Hum Reprod"},{"issue":"12","key":"9623_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10815-010-9476-6","volume":"27","author":"M Chuang","year":"2010","unstructured":"Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, Polotsky AJ. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet. 2010;27(12):711\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"9623_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fertnstert.2016.09.044","volume":"107","author":"N Pereira","year":"2017","unstructured":"Pereira N, Friedman C, Hutchinson AP, Lekovich JP, Elias RT, Rosenwaks Z. Increased odds of live birth in fresh in vitro fertilization cycles with shorter ovarian stimulation. Fertil Steril. 2017;107(1):104\u2013e1092.","journal-title":"Fertil Steril"},{"issue":"7","key":"9623_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10815-014-0253-9","volume":"31","author":"A Ryan","year":"2014","unstructured":"Ryan A, Wang S, Alvero R, Polotsky AJ. Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. J Assist Reprod Genet. 2014;31(7):837\u201342.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"9623_CR39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.fertnstert.2020.06.021","volume":"114","author":"RS Gerber","year":"2020","unstructured":"Gerber RS, Fazzari M, Kappy M, Cohen A, Galperin S, Lieman H, Jindal S, Buyuk E. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study. Fertil Steril. 2020;114(6):1225\u201331.","journal-title":"Fertil Steril"},{"key":"9623_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fendo.2020.00192","volume":"11","author":"Z Blumenfeld","year":"2020","unstructured":"Blumenfeld Z What is the best regimen for ovarian stimulation of poor responders in ART\/IVF? Front Endocrinol. 2020;11:192. https:\/\/doi.org\/10.3389\/fendo.2020.00192.","journal-title":"Front Endocrinol"},{"issue":"8","key":"9623_CR41","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/humrep\/deab152","volume":"36","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, Yarali H, Vuong LN, Carvalho JF, \u00d6zbek \u0130Y, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C. Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients. Hum Reprod. 2021;36(8):2157\u201369.","journal-title":"Hum Reprod"},{"issue":"4","key":"9623_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0015-0282(16)56650-3","volume":"61","author":"K Pantos","year":"1994","unstructured":"Pantos K, Meimeth-Damianaki T, Vaxevanoglou T, Kapetanakis E. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program. Fertil Steril. 1994;61(4):709\u201313.","journal-title":"Fertil Steril"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09623-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:02:33Z","timestamp":1791471753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9623"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09623-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted with approval from the Ethics Committee of Children\u2019s Hospital of Shanxi and Women Health Center of Shanxi (No.IRB-KYSB-2023-024). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1133"}}